Semper Paratus Acquisition Corporation (LGST)

NASDAQ: LGST · IEX Real-Time Price · USD
0.00 (0.00%)
At close: Sep 19, 2023, 12:00 AM
-0.01 (-0.09%)
After-hours: Sep 21, 2023, 4:00 PM EDT
Market Cap 171.13M
Revenue (ttm) n/a
Net Income (ttm) 5.67M
Shares Out 15.82M
EPS (ttm) 0.12
PE Ratio 90.17
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 2,900
Open 10.80
Previous Close 10.82
Day's Range 10.80 - 10.82
52-Week Range 10.11 - 12.03
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About LGST

Semper Paratus Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company intends to acquire companies operating in the transportation, supply chain, and logistics industries. Semper Paratus Acquisition Corporation was incorporated in 2021 and is based in New York, New York. Semper Paratus Acquisition Corporation operates as a subsidiary of Ssvk Associates, Llc. [Read more]

Industry Shell Companies
Sector Financials
IPO Date Nov 4, 2021
Country United States
Stock Exchange NASDAQ
Ticker Symbol LGST
Full Company Profile

Financial Performance

Financial Statements


Semper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio Inc

New York, NY, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (Nasdaq: LGST) (“Semper Paratus”), a publicly traded special purpose acquisition company, today announced the fi...

10 days ago - GlobeNewsWire

Tevogen Bio to Become Publicly Listed on NYSE via Business Combination with Semper Paratus Acquisition Corporation

New York, NY, June 29, 2023 (GLOBE NEWSWIRE) -- Tevogen Bio Inc, a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in virolo...

3 months ago - GlobeNewsWire